SciTech Development
SciTech Development is a clinical-stage biotechnology company dedicated to revolutionizing cancer treatment through innovative drug delivery platforms and targeted therapies. Their mission is to develop cost-effective therapeutics that deliver transformative clinical outcomes with less patient trauma, focusing on advancing their clinical programs to bring effective cancer treatments to patients worldwide.
Industries
Nr. of Employees
small (1-50)
SciTech Development
Grosse Pointe Farms, Michigan, United States, North America
Products
Nanoparticle‑formulated fenretinide for intravenous oncology use
A patent‑protected aqueous nanoparticle formulation combining a poorly soluble small molecule with phospholipid bilayers to enable high‑dose IV administration, improved tissue delivery, and an optimized pharmacokinetic profile for oncology indications.
Nanoparticle‑formulated fenretinide for intravenous oncology use
A patent‑protected aqueous nanoparticle formulation combining a poorly soluble small molecule with phospholipid bilayers to enable high‑dose IV administration, improved tissue delivery, and an optimized pharmacokinetic profile for oncology indications.
Services
Early‑phase clinical development and trial management
Design and operational management of Phase 1 accelerated dose‑escalation trials including site activation, safety monitoring, PK/PD assessments, and MTD determination.
Drug formulation and delivery platform engineering
Engineering of nanoparticle formulations to improve solubility, bioavailability, and targeted tissue delivery for small‑molecule therapeutics; development of patentable formulations.
Regulatory filing and IND pathway support
Execution of regulatory strategies to obtain IND acceptance and secure designations that support clinical development timelines.
Partnership coordination for cGMP clinical manufacturing
Selection and management of contract manufacturers to produce clinical‑grade nanoparticle formulations under cGMP sterile conditions and to support manufacturing scale‑up.
Early‑phase clinical development and trial management
Design and operational management of Phase 1 accelerated dose‑escalation trials including site activation, safety monitoring, PK/PD assessments, and MTD determination.
Drug formulation and delivery platform engineering
Engineering of nanoparticle formulations to improve solubility, bioavailability, and targeted tissue delivery for small‑molecule therapeutics; development of patentable formulations.
Regulatory filing and IND pathway support
Execution of regulatory strategies to obtain IND acceptance and secure designations that support clinical development timelines.
Partnership coordination for cGMP clinical manufacturing
Selection and management of contract manufacturers to produce clinical‑grade nanoparticle formulations under cGMP sterile conditions and to support manufacturing scale‑up.
Expertise Areas
- Nanoparticle drug delivery
- Formulation development for poorly soluble therapeutics
- Early‑phase clinical trial management (Phase 1a/b)
- GMP clinical manufacturing coordination
Key Technologies
- Nanovesicle/nanoparticle formulations
- Phospholipid bilayer encapsulation
- Liposomal encapsulation
- Nanosuspensions